Peer-reviewedCC BY-NDAnnals of medicine and surgery (2012)
Borderline resectable pancreatic ductal adenocarcinoma: a narrative review
- 1Department of General Surgery, National Medical College, Birgunj, Parsa, Nepal
- 2Department of Surgical Gastroenterology, Kist Medical College, Lalitpur, Nepal
Related
- Long-Term Outcomes of Anatomical and Biological Borderline Resectable Pancreatic Ductal Adenocarcinoma After Gemcitabine/S-1-Based Neoadjuvant Chemoradiotherapy
- Transcriptomic FOLFIRINOX sensitivity signatures stratify overall survival and reveal directional reclassification after neoadjuvant FOLFIRINOX in borderline resectable and locally advanced pancreatic cancer
- Prognostic and Spatial Organization of Tertiary Lymphoid Structures in Pancreatic Ductal Adenocarcinoma
- Identification of miR-615-5p/ID1 axis crucial in the pathogenesis of pancreatic ductal adenocarcinoma (PDAC)
- Immunohistochemical Expression of M30, BCL-2, BAX, and Ki-67 in Pancreatic Ductal Adenocarcinoma: Association with Clinicopathological Features
BibTeX
@article{chhetri2026borderline,
title = {{Borderline resectable pancreatic ductal adenocarcinoma: a narrative review}},
author = {Rupesh Thapa Chhetri and Krisha Maharjan},
journal = {Annals of medicine and surgery (2012)},
year = {2026},
month = sep,
url = {https://europepmc.org/article/PMC/PMC13657568},
note = {CC BY-ND},
}
RIS
TY - JOUR
TI - Borderline resectable pancreatic ductal adenocarcinoma: a narrative review
AU - Rupesh Thapa Chhetri
AU - Krisha Maharjan
PY - 2026
DA - 2026/09/02
JO - Annals of medicine and surgery (2012)
UR - https://europepmc.org/article/PMC/PMC13657568
SN - 2049-0801
ER -